| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 6e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |